Clinical trial
Cholesterol and Pharmacogenetic Study
NCT00451828 · UCSF Benioff Children's Hospital Oakland, Other · Completed
Key facts
| NCT number | NCT00451828 |
|---|---|
| Title | Cholesterol and Pharmacogenetic Study |
| Official title | Cholesterol and Pharmacogenetic Study |
| Acronym | CAP |
| Lead sponsor | UCSF Benioff Children's Hospital Oakland, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH San Francisco General Hospital University of California, Los Angeles Cedars-Sinai Medical Center University of Washington Duke University |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hyperlipidemia, Hypercholesterolemia, Coronary Heart Disease, Cardiovascular Disease |
| Intervention type | Drug |
| Interventions | Simvastatin |
| Enrollment | 1,000 |
| Start date | Mar 1, 2002 |
| Primary completion | Oct 1, 2004 |
| First posted | Mar 26, 2007 |
| Last update posted | Oct 5, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: